| GANVADO AMGEN INC.
1936270 14 Dec 2018 | on 21 Dec 2020 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, asthma, celiac disease, atopic dermatitis, chronic obstructive pulmonary disease, osteoarthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, metabolic diseases and disorders, namely, diabetes, hypoglycemia, hypercalcemia, hyperparathyroidism, hypercholesterolemia, hypocalcemia, obesity, gout, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours | | | GANVADO AMGEN INC. A CORPORATION OF DELAWARE
1635212 15 Jul 2013 | on 06 Feb 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, infectious diseases and minimal residual disease. | |